2003-11-17
Extended duration of the detectable stage by adding HPV test in cervical cancer screening
Publication
Publication
British Journal of Cancer , Volume 89 - Issue 10 p. 1830- 1833
The human papillomavirus test (HPV) test could improve the (cost-) effectiveness of cervical screening by selecting women with a very low risk for cervical cancer during a long period. An analysis of a longitudinal study suggests that women with a negative Pap smear and a negative HPV test have a strongly reduced risk of developing cervical abnormalities in the years following the test, and that HPV testing lengthens the detectable stage by 2-5 years, compared to Pap smear detection alone.
| Additional Metadata | |
|---|---|
| , | |
| doi.org/10.1038/sj.bjc.6601355, hdl.handle.net/1765/66798 | |
| British Journal of Cancer | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Van Den Akker-van Marie, M., van Ballegooijen, M., Rozendaal, L., Meijer, C., & Habbema, D. (2003). Extended duration of the detectable stage by adding HPV test in cervical cancer screening. British Journal of Cancer, 89(10), 1830–1833. doi:10.1038/sj.bjc.6601355 |
|